NITRO clinical trial information

Dataset Name: A Phase III, randomised trial of adding nitroglycerin to first line chemotherapy for advanced non-small cell lung cancer
Author: Prof Andrew Davidson, Royal Perth Hospital
Thoracic Oncology Group Australasia
Funding: Cancer Council WA, Cancer Council QLD, Cancer Council NSW, National Health and Medical Research Council.
DOI: 10.58106/914n-jz74
Date made available: 2023

Subject: Chemotherapy
Individual participant data
Patient sample size: 372

Dataset description: Data for 372 adult patients with advanced non-small cell lung cancer. Treatment regime was standard chemotherapy with (n=185) or without (n=187) application of a nitroglycerin 25 mg patch. Study assessments were carried out at baseline before randomization, then every 3 weeks during chemotherapy, and every 4 weeks from completion of chemotherapy until disease progression. Dataset includes: Progression free survival, overall survival data, demographic data, diagnostic data, treatment data, quality of life data, objective tumour response. (RECIST 1.1), adverse events.

Requests for Data: Access can be requested via the Health Data Australia catalogue. Search for the ACTRN number in the catalogue to find datasets associated with this trial or email enquiries to

Link to main trial page

Link to publication